BIOMED PRIVATE LIMITED

Bio Typh

Typhoid fever is a contagious and severe disease due to a bacterium called Salmonella typhi. It mostly affects school-age children. Typhoid fever is a widespread disease that is easily transmitted. It is present in all tropical regions, including our country where it affects most of the population. Each year, over 33 million people worldwide suffer Typhoid fever and about 200,000 die. Bio-Med successfully developed Vi polysaccharide typhoid vaccine and launched it in November 1998. Vi Polysaccharide Typhoid vaccine is the first indigenously manufactured Vi antigen based typhoid vaccine. It is manufactured as per WHO requirements of biological substance no. 48 & WHO TRS 840, 1994.
DESCRIPTION : 
Vi Polysaccharide Typhoid vaccine is a clear solution containing purified Vi capsular polysaccharide of Salmonella typhi for prevention of typhoid fever. It contains 25 mcg of Vi antigen per dose and is in liquid form.
COMPOSITION :
Each dose of vaccine contains :

INDICATIONS :
• Children aged 2 years or more and adults.
• Travellers proceeding to endemic areas. 
• Mela / fair visitors. 
• Vendors of unprotected food. 
• Settlers in poor hygienic areas.
PRESENTATION :

• Single dose vial (0.5ml) 
• 5 dose vial (2.5ml)

DOSAGE AND ADMINISTRATION : 
• Inject 0.5 ml in adults and children over 2 years of age by intramuscular or subcutaneous route. 
• Vaccine provides protection for a period of three years.
• Reimmunization every three years under conditions of repeated or continued exposure is recommended. 
• Prevention becomes effective 2-3 weeks after immunization.

CONTRA- INDICATION : 
• Hypersensitivity to any constituent of the vaccine.
• Pregnant and lactating women. 
• In the event of fever or severe infection. 

SIDE EFFECT : 
Mild local pain or induration and mild fever may occur during the 48 hours following injection in few cases.